Overview

Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas...

Open

$0.00

Prior close

$43.52

Today's high

$0.00

Today's low

$0.00

52 Week high

$86.74

52 Week low

$41.19

News

Zacks Investment Research • 5 days ago • IONS

Earnings Preview: Ionis Pharmaceuticals (IONS) Q3 Earnings Expected to Decline

Seeking Alpha • 7 days ago • IONS

Artisan Mid Cap Fund Q3 2026 Portfolio Update

The Motley Fool • 24 days ago • IONS

Alnylam vs. Ionis: Here's the Better Bad-News Buy

Zacks Investment Research • 25 days ago • IONS

NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido

Zacks Investment Research • about 1 month ago • IONS

4 RNA Therapeutics Stocks Leading the Next Wave of Innovation